1-9 of 9
H. Link
Close
Sort by
Journal Articles

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials).

C. Kelaidi, L. Ades, S. Chevret, M. A. Sanz, A. Guerci, X. Thomas, S. de Botton, E. Raffoux, C. Rayon, J. de la Serna, A. Ferrant, D. Bron, H. Link, N. Fegueux, D. Bordessoule, F. Rigal-Huguet, A.M. Stoppa, A. Vekhoff, S. Meyer-Monard, M. Fey, S. Castaigne, H. Dombret, L. Degos, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 890.
https://doi.org/10.1182/blood.V106.11.890.890
Published: 2005
Journal Articles

Efficacy of Rituximab Combined in Salvage- and High Dose-Therapy (HDT) for Patients with Relapsed NHL; Interim Analysis of a Multicenter Phase II Study.

G. Hess, MD, T. Flohr, MD, N. Frickhofen, MD, H. Wolf, MD, M. Gramatzki, MD, H. Link, MD, N. Peter, MD, N. Basara, MD, N. Schmitz, MD, A. Banat, MD, M. Kneba, MD, C. Huber, MD, G. Derigs, MD
Journal: Blood
Blood (2004) 104 (11): 1325.
https://doi.org/10.1182/blood.V104.11.1325.1325
Published: 2004
Journal Articles

Transplantation of allogeneic CD34+ blood cells

H Link, L Arseniev, O Bahre, JG Kadar, H Diedrich, H Poliwoda
Journal: Blood
Blood (1996) 87 (11): 4903–4909.
https://doi.org/10.1182/blood.V87.11.4903.bloodjournal87114903
Published: 1996
Journal Articles

Combined transplantation of allogeneic bone marrow and CD34+ blood cells

H Link, L Arseniev, O Bahre, RJ Berenson, K Battmer, JG Kadar, R Jacobs, J Casper, J Kuhl, J Schubert
Journal: Blood
Blood (1995) 86 (7): 2500–2508.
https://doi.org/10.1182/blood.V86.7.2500.2500
Published: 1995
Journal Articles

A controlled trial of recombinant human erythropoietin after bone marrow transplantation

H Link, MA Boogaerts, AA Fauser, S Slavin, J Reiffers, NC Gorin, AM Carella, F Mandelli, S Burdach, A Ferrant
Journal: Blood
Blood (1994) 84 (10): 3327–3335.
https://doi.org/10.1182/blood.V84.10.3327.3327
Published: 1994
Journal Articles

Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter]

P Fenaux, E Wattel, E Archimbaud, M Sanz, B Hecquet, N Fegueux, A Guerci, H Link, M Fey, S Castaigne
Journal: Blood
Blood (1994) 84 (2): 666–667.
https://doi.org/10.1182/blood.V84.2.666.666
Published: 1994
Journal Articles

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

P Fenaux, MC Le Deley, S Castaigne, E Archimbaud, C Chomienne, H Link, A Guerci, M Duarte, MT Daniel, D Bowen
Journal: Blood
Blood (1993) 82 (11): 3241–3249.
https://doi.org/10.1182/blood.V82.11.3241.3241
Published: 1993
Journal Articles

A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma

H Link, MA Boogaerts, AM Carella, A Ferrant, H Gadner, NC Gorin, I Harabacz, JL Harousseau, P Herve, J Holldack
Journal: Blood
Blood (1992) 80 (9): 2188–2195.
https://doi.org/10.1182/blood.V80.9.2188.2188
Published: 1992
Journal Articles

CD16- CD56+ natural killer cells after bone marrow transplantation

R Jacobs, M Stoll, G Stratmann, R Leo, H Link, RE Schmidt
Journal: Blood
Blood (1992) 79 (12): 3239–3244.
https://doi.org/10.1182/blood.V79.12.3239.3239
Published: 1992